Update: US District Court Rules Against MorphoSys’ Cancer Immunotherapy Patents
Update (01/02/2019): MorphoSys has agreed to end its long-running legal battle with Genmab and Janssen, after…
28/01/2019 - 3 minutes
Immuno-oncology
Personalized Immunotherapy for Brain Cancer Succeeds in Clinical Trials
A European trial has proved the feasibility and efficacy of treating cancer with a personalized…
20/12/2018 - 3 minutes
Mastering the Competitive World of Immuno-oncology
In recent years the oncology world has focused on using the immune system to target…
25/10/2018 - 5 minutes
How To Break Into The Crowded Immuno-Oncology Space
The field of immuno-oncology promises to make anti-cancer treatments more effective than ever. But in…
11/09/2018 - 6 minutes
Affimed Collaborates with Genentech in Cancer Immunotherapy Deal Worth €4.4B
The German biotech will partner with Genentech, part of the Roche Group, to develop targeted…
29/08/2018 - 2 minutes
Update: Gilead and Novartis’s CAR T-Cell Therapies Approved in Europe
Update: Following on from earlier approvals in the US, the European Commission announced it has given…
28/08/2018 - 4 minutes
Update: Yet Another ADC Company Makes Bank, This Time in Series B
Update (29.06.2018): NBE Therapeutics has extended its Series B fundraising round by 20M CHF (€17.3M),…
29/06/2018 - 3 minutes
German Biotech Expands Oncology Deal with Bluebird bio to $1.5Bn
Medigene and bluebird bio are increasing the number of cancer targets against which to develop TCR…
14/05/2018 - 2 minutes
Scottish Biotech Boosts its CAR-T Pipeline for Cancer and HIV
TC Biopharm has partnered with Scotia Biologics to produce tumor-specific antibodies for a new generation…
08/05/2018 - 2 minutes
Novartis and Gilead’s CAR-T Therapies Now Compete for the Same Cancer Patients
The FDA has approved the use of Novartis' CAR-T therapy Kymriah in adult patients with…
02/05/2018 - 2 minutes
The First CAR-T Therapy Is Not Living Up to Commercial Expectations
Novartis' Kymriah, the first approved CAR-T therapy worldwide, has performed far below sales expectations in…
23/04/2018 - 3 minutes
French CAR-T Developer Raises $164M Despite a Challenging Road
Cellectis has raised $164M (€132M) in a follow-on offering to further develop its CAR-T technology in…
11/04/2018 - 3 minutes
